Med Cross India Pharmaceuticals LLP
About Med Cross India Pharmaceuticals LLP
Data last updated:
Med Cross India Pharmaceuticals LLP is a limited liability partnership (LLP) based in New Delhi, Delhi, India. It operates in the paper and paper products segment of the paper and packaging sector. It was incorporated on 15 December 2022.
The LLP is registered with the Registrar of Companies (ROC), Delhi, under LLPIN ABZ-4715.
The LLP has a total obligation of contribution of ₹1 Lakh. It is led by designated partners Kunwar Asif Aftab and Shah Nawaz Adil.
Its latest statement of accounts is for the year ended 31 March 2023. The registered office is at Hno. J – 76/1 S/F Flat No. 210 Ashiana Complex Thokar No. 4, Abul Fazal Enclave Part – 1 Okhla Near Unani Hospital, New Delhi, Delhi, India – 110025.
Company details
Contact details
Med Cross India Pharmaceuticals LLP's registered office is in New Delhi, Delhi.
- Registered AddressHno. J – 76/1 S/F Flat No. 210 Ashiana Complex Thokar No. 4, Abul Fazal Enclave Part – 1 Okhla Near Unani Hospital, New Delhi, Delhi, India – 110025
- IndustryPaper, Paper & Paper Products, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Med Cross India Pharmaceuticals LLP
FY 2023 filings availableFinancial Statement Summary
| Statement of Account and Solvency | FY 2022-23 |
|---|---|
| Income and Expenditure | |
| Turnover | |
| Other Income | |
| Total Income | |
| Purchases and Direct Costs | |
| Personnel Expenses | |
| Administrative Expenses | |
| Interest | |
| Depreciation | |
| Total Expenses | |
| Profit Before Tax | |
| Tax | |
| Profit After Tax | |
| Profit Transferred to Partners | |
| Assets and Liabilities | |
| Partners' Contribution | |
| Reserves and Surplus | |
| Secured Loans | |
| Unsecured Loans | |
| Trade Payables | |
| Other Liabilities and Provisions | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Loans and Advances | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Statement of Account and Solvency | FY 2022-23 |
|---|---|
| Profitability | |
| Net Profit Margin | |
| Return on Partners' Funds | |
| Return on Assets | |
| Liquidity and Debt | |
| Current Ratio | |
| Debt to Partners' Funds | |
| Interest Coverage | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Turnover Growth | |
| Profit Growth | |
To see the full financial statements and ratios of Med Cross India Pharmaceuticals LLP, buy the company report.
Designated partners of Med Cross India Pharmaceuticals LLP
Med Cross India Pharmaceuticals has 2 designated partners on record. No former designated partners are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kunwar Asif Aftab Also directs: World Health Ocean India Pharma LLP | Designated Partner | 15 Dec 2022 | 3 Years 10 Months | Current |
| Shah Nawaz Adil | Designated Partner | 15 Dec 2022 | 3 Years 10 Months | Current |
Legal cases
No court or tribunal cases involving Med Cross India Pharmaceuticals LLP are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Med Cross India Pharmaceuticals LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Med Cross India Pharmaceuticals LLP; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Med Cross India Pharmaceuticals LLP has 2 designated partner changes on record since 2022: 2 appointments. The latest: Kunwar Asif Aftab was appointed as Designated Partner on 15 Dec 2022.
Frequently asked questions
Med Cross India Pharmaceuticals is an active limited liability partnership based in New Delhi, Delhi, India. The LLP works in paper and paper products, within the paper industry. It was incorporated on 15 December 2022 (4+ years old) and is registered under LLPIN ABZ-4715.
Med Cross India Pharmaceuticals has 2 current designated partners:
- Kunwar Asif Aftab - Designated Partner
- Shah Nawaz Adil - Designated Partner
The latest financial statements of Med Cross India Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 31 March 2024. Year-wise statements from FY 2023 are in the company report.
The LLPIN (Limited Liability Partnership Identification Number) of Med Cross India Pharmaceuticals is ABZ-4715. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Med Cross India Pharmaceuticals was incorporated on 15 December 2022, making it 4+ years old. It is registered with the Registrar of Companies, Delhi.
Kunwar Asif Aftab was appointed as Designated Partner on 15 Dec 2022. Shah Nawaz Adil was appointed as Designated Partner on 15 Dec 2022.
The registered office of Med Cross India Pharmaceuticals is at Hno. J – 761 SF Flat No. 210 Ashiana Complex Thokar No. 4, Abul Fazal Enclave Part – 1 Okhla Near Unani Hospital, New Delhi, Delhi, India – 110025.
Med Cross India Pharmaceuticals operates in the paper industry, in the paper and paper products segment.
Med Cross India Pharmaceuticals can be reached at its registered office: Hno. J – 761 SF Flat No. 210 Ashiana Complex Thokar No. 4, Abul Fazal Enclave Part – 1 Okhla Near Unani Hospital, New Delhi, Delhi, India – 110025.
Med Cross India Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Delhi.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
